Science Diplomacy Roles

Lessons learned from global collaboration As a young faculty member, I envied faculty from Asia, Europe, and further afield. They had high status and large PhD programs, yet did not have the publications required for tenure at my home institution in the United States. I was envious because I did not yet understand that we were doing fundamentally different jobs. Over the past two decades, I have visited and worked with schools across Asia, Europe, and Australia/New Zealand. What once evoked envy now reflects something more useful: different systems, different constraints, and different definitions of success. That shift changed how I approach global collaboration. A few lessons. First, teaching anchors the profession everywhere. Teaching cycles, grading structures, and program demands determine when work can happen. If you ignore this, coordination will fail. Second, service is no longer cleanly divided across systems. In the past, US scholars emphasized editorial roles and external visibility, while scholars elsewhere often carried heavier administrative responsibilities. That distinction is fading. Many faculty now juggle editorial work, institutional leadership, and external engagement at the same time. Effective collaboration starts with recognizing that everyone is managing multiple roles. Third, definitions of research success differ. Rankings have globalized expectations around top journals, but local systems still reward different outputs. Policy reports, industry engagement, grant capture, and societal impact are core activities in many contexts. If you screen collaborators only on journal lists, you will miss strong partners with complementary strengths. Fourth, industry access varies, and you should not assume it transfers. In some countries, access to firms and data is embedded in the role. In others, it is harder to secure. Global collaborators can expand access, but only if expectations are made explicit early. Fifth, coordination is easier and harder at the same time. Remote work, shared tools, and AI reduce friction. At the same time, time zones, institutional rules, data restrictions, and geopolitical pressures introduce new constraints. Successful collaboration now requires more structure, not less. Finally, PhD training models differ in meaningful ways. Some systems emphasize independence; others emphasize close supervision. These differences shape how students work, communicate, and contribute. If you ignore this, frustration is predictable. If you understand it, you can design better collaborations. I no longer assume that one model is superior. But I do pay close attention to fit. Global collaboration is not just about expanding your network. It is about expanding how you understand the work itself. #academicjourney #collaboration

It took me a long time to be able to define, rest in, and identify my career path within science. My roles were often framed around partnerships or international collaboration, yet what I was doing on a daily basis was working at the boundary of institutions, disciplines, systems and ideas rather than simply managing relationships. Then in 2010, the UK Royal Society and the AAAS released a seminal report on science diplomacy. That report helped define the conceptual underpinnings of the field. The 2025 revision simplifies this framing and calls for greater conceptual clarity about both theory and practice. For me, the 2010 report was important because it recognised the need to professionalise science diplomacy. It highlighted the need to strengthen the capacities of scientists so they can operate at the intersection of science and international relations. It also recognised the existence of professionals who work as boundary spanners. That recognition shifted my own professional identity. It gave me language for what I was already doing. I began seeing more clearly how trust, mutual respect, relational practice, consistency, and shared understanding were central values. They were shaping how I built partnerships and understood my role within them. Later, academic grounding on science advice added further depth to that professional identity. It gave me language and tools to understand, in a more rigorous way, the types of organisations I was working with. It helped me to hold science-policy tensions and to navigate differences in language and approach across scientific disciplines. As such, I refer to myself as a boundary spanner working at the intersection of science advice and science diplomacy, using these mechanisms to support international scientific cooperation. Stepping back to the system, I have often wondered why this career path is not more visible or deliberately enabled within scientific institutions. If boundary spanning is so central to the practice of international scientific cooperation, why is it not more clearly recognised and intentionally supported? The 2025 revision of the science diplomacy report makes an important shift. It recognises that science diplomacy is no longer primarily about soft power. At a time of fundamental global change, scientific cooperation cannot be assumed. Science diplomacy becomes the mechanism that deliberately enables and sustains it. In this context, science diplomacy is not peripheral to institutional work. It is core to it. Funding agencies, academies of science, professional societies and scientific think tanks are boundary organisations where science diplomacy enables the intersection of disciplines, science, policy, practice and cooperation. The question is no longer whether this work exists. It clearly does. The question is whether it is seen and named, and whether the professional identities that sustain it are understood.

When I started my research career, I thought there was one right way to land a position overseas. After moving across India, Germany, Finland, Czech Republic, US, I have learned there are actually four major routes, and they work the same whether you are applying for a PhD or a postdoc. 1. The Direct Approach: Email the right supervisor. Still the fastest route, still the most underrated. PhD: professors with open projects or advertised RA roles. Postdoc: PIs with active grants or recent papers that match your skillset. 2. The Fellowship Route: You bring the money; you pick the lab. Prestige + independence in one move. PhD: DAAD, Commonwealth, Fulbright, Chevening, CSC, Erasmus Mundus, Rhodes, Gates Cambridge. Postdoc: MSCA, HFSP, EMBO, Humboldt, Fulbright, JSPS, Branco Weiss. 3. Structured Programs: Formal cycles, panel interviews, real cohort experience. PhD: MPI IMPRS, EMBL PhD, Crick PhD, Pasteur, ETH, Cambridge/Oxford DTPs. Postdoc: EMBL, Crick, Carnegie, Max Planck, HHMI, Junior Fellows schemes. 4. The Vacancy Route: Clear scope, funded day one. You step into an existing grant. PhD: FindAPhD, EURAXESS, university job boards, PhD-specific project ads. Postdoc: Nature Careers, EURAXESS, ResearchGate, LinkedIn, Science Careers. These aren't competing strategies, they're a portfolio. The strongest candidates I have seen try all four in parallel. Each one sharpens how you articulate your science. And honestly, that's the real win, regardless of which path lands first. Except these 4 major strategies some other ways that works too are: Conference & Workshop Networking Supervisor Referral Collaboration-to-Position Pipeline Social Media Direct Outreach 🙂 Feel free to reach out for more information.

Why many PharmD graduates are transitioning into Medical Affairs. During PharmD training, most students are primarily exposed to clinical pharmacy roles in hospitals. However, the pharmaceutical industry offers several science-driven career paths where PharmD training is highly relevant. One of the most prominent options is Medical Affairs. Medical Affairs professionals work at the intersection of clinical science, medical communication, and healthcare collaboration. Roles in this field often involve interpreting clinical evidence, engaging with healthcare professionals, and supporting evidence-based medical strategy. PharmD graduates bring strong expertise in pharmacology, therapeutics, clinical literature evaluation, and medication safety, which aligns closely with the requirements of Medical Affairs roles. Common entry positions include Medical Affairs Associate, Medical Information Specialist, and Medical Science Liaison roles within pharmaceutical companies. For PharmD students and interns exploring healthcare careers beyond traditional clinical roles, Medical Affairs is an option worth learning about early. #PharmD #MedicalAffairs #MedicalScienceLiaison #PharmaCareers #PharmaceuticalIndustry #ClinicalResearch #HealthcareCareers

The Crucial Role of Medical Science Liaisons in Accelerating Phase 3 Clinical Trials As pharmaceutical race to bring new therapies to market, the ability to quickly and efficiently execute Phase 3 clinical trials has become mission-critical. These large-scale studies, which often involve hundreds to thousands of patients across dozens of sites worldwide, are the final hurdle before regulatory approval. Maximizing the speed and quality of data generation during this phase can make the difference between getting a drug to patients on time or facing costly delays. This is where medical science liaisons (MSLs) can play a pivotal role. These highly specialized field-based medical experts are uniquely positioned to support Phase 3 trials in several key ways: Site Identification and Enrollment MSLs maintain deep relationships with key opinion leaders (KOLs) and clinicians at leading academic centers and community practices. They understand the patient populations, research capabilities, and clinical interests of these sites. MSLs can leverage these insights to rapidly identify the most suitable Phase 3 trial locations, expediting site selection and activation. Furthermore, MSLs can work closely with investigators to educate them on the clinical protocol, highlight the scientific rationale, and ensure they are equipped to effectively recruit and enroll qualified patients. This "high-touch" approach can significantly boost site performance and patient accrual. Data Quality and Integrity Beyond site selection, MSLs play a vital role in supporting data quality and integrity throughout the trial. They routinely visit active sites, meeting face-to-face with investigators and research coordinators. This allows them to provide real-time training, address protocol deviations, and troubleshoot operational challenges. Importantly, MSLs also act as a conduit between the clinical sites and the company's medical and regulatory teams. They can rapidly escalate issues, provide contextual insights, and help resolve problems before they impact data quality or trial timelines. By deepening the site team's appreciation for the trial's scientific rationale and clinical relevance, MSLs can bolster investigator commitment, enhance protocol compliance, and support robust data generation. This scientific engagement is especially critical for complex, novel therapies where site education and alignment are paramount. In an era of unprecedented innovation in medicine, the ability to execute efficient, high-quality Phase 3 trials has never been more important. Medical science liaisons, with their unique combination of scientific acumen, clinical insights, and relationship-building skills, are poised to play a pivotal role in accelerating this vital stage of drug development. As the pharmaceutical industry continues to evolve, the strategic value of the MSL function will only continue to grow.

🌍 The Pharma Industry’s Best-Kept Secret — The Medical Science Liaison (MSL) Role When I first came across the term “Medical Science Liaison,” I’ll be honest — I didn’t really understand what it meant. Like most pharmacy and medical graduates, I thought the only career paths ahead were hospital practice, academia, or preparing for competitive exams like NEET PG, FMGE, USMLE, or AMC. But over time, I discovered something that completely changed my perspective — 💡 The Medical Science Liaison (MSL) role isn’t just another job in pharma. It’s one of the fastest-growing, most respected, and most impactful careers in the healthcare ecosystem today. So what exactly does an MSL do? Think of them as the scientific bridge between the pharmaceutical industry and the medical community. They don’t sell products — they share science. They don’t push prescriptions — they build trust. An MSL’s job is to translate complex clinical data into meaningful insights for doctors and healthcare professionals. They discuss research, support clinical trials, present evidence, and ensure every conversation around a new therapy stays factual, unbiased, and patient-centric. In an era where doctors want data-driven clarity, not marketing pitches — MSLs have become the voice of credible science and that’s what makes this role so powerful. You’re not just representing a company — you’re representing knowledge. You’re not just promoting a molecule — you’re shaping how future treatments reach patients. If you’re a doctor, pharmacist, dentist, PhD, or life science graduate who loves scientific dialogue, continuous learning, and meaningful collaboration — the MSL role could be your perfect career fit. 🌟 It’s a path that blends science, credibility, and purpose — where your expertise doesn’t just advance your career, it helps advance medicine itself.

Ever felt like you love medicine but don’t see yourself spending your entire working life within the four walls of a hospital? If you’re a doctor, pharmacist, or life sciences graduate wondering what else is out there, Medical Affairs could be your perfect fit. Let’s break it down. 1️⃣ Do You Love Science but Not the Long Shifts? If you’re passionate about medicine but tired of endless rounds, overnight calls, and unpredictable schedules, Medical Affairs lets you stay in the field without the exhaustion. ✅ You still get to work with the latest treatments, clinical data, and medical advancements. ✅ You still play a role in improving patient care...just on a bigger scale. ✅ And best of all? No emergency calls, no night shifts, no burnout. 2️⃣ Do You Like Explaining Medical Concepts? Ever found yourself teaching colleagues, mentoring juniors, or simplifying complex topics for others? If you enjoy breaking down science in a way people understand, you’ll love Medical Affairs. ✅ Instead of treating patients, you’ll educate doctors and healthcare professionals about new therapies. ✅ You’ll get to speak at conferences, train internal teams, and be the go-to expert on medical strategy. ✅ It’s not sales...it’s about sharing accurate, evidence-based medicine. If you’ve ever loved the teaching side of medicine, this career is a natural fit. 3️⃣ Do You Want More Career Growth? Let’s be honest...clinical careers have a slow growth curve. You wait years for promotions, better pay, or even work-life balance. Medical Affairs? The opportunities grow faster. ✅ You start as a Medical Science Liaison (MSL) or Medical Advisor. ✅ With experience, you move into leadership...Medical Manager, Director, or even VP. ✅ You can work in Pharma, biotech, health tech...there’s no limit. If you want a career that rewards your knowledge and skills, not just seniority, this is it. 4️⃣ Do You Want to Influence Healthcare at a Bigger Level? In a hospital, you help one patient at a time. In Medical Affairs, you impact thousands—by shaping drug development, clinical guidelines, and treatment access. ✅ You work with regulators, policymakers, and global health experts. ✅ You ensure the right information reaches doctors and patients. ✅ You get to be part of major medical breakthroughs. It’s healthcare, just on a bigger stage. If you resonate with at least 3 out of these 4 points, Medical Affairs could be an excellent career move for you. -------- Feeling Stuck? Let’s Figure It Out Together. I know career transitions can feel overwhelming. I’ve been there myself. That’s why I help healthcare professionals like you: 💡 Understand the industry 📄 Build the right skills 🎯 Prepare for interviews Want to explore Medical Affairs for yourself? Drop me a DM or comment below—I’d love to help you find the right path. 🚀